Global Targeted Protein Degradation Drug Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Targeted Protein Degradation Drug market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Targeted Protein Degradation Drug Industry Forecast” looks at past sales and reviews total world Targeted Protein Degradation Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Targeted Protein Degradation Drug sales for 2024 through 2030. With Targeted Protein Degradation Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Protein Degradation Drug industry.
This Insight Report provides a comprehensive analysis of the global Targeted Protein Degradation Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Protein Degradation Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Protein Degradation Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Protein Degradation Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Protein Degradation Drug.
United States market for Targeted Protein Degradation Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Targeted Protein Degradation Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Targeted Protein Degradation Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Targeted Protein Degradation Drug players cover Arvinas, Kangpu Biopharmaceuticals, Ranok Therapeutics, Accutar Biotechnology and BeiGene Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Protein Degradation Drug market by product type, application, key players and key regions and countries.
Segmentation by type
The global Targeted Protein Degradation Drug market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Targeted Protein Degradation Drug Industry Forecast” looks at past sales and reviews total world Targeted Protein Degradation Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Targeted Protein Degradation Drug sales for 2024 through 2030. With Targeted Protein Degradation Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Protein Degradation Drug industry.
This Insight Report provides a comprehensive analysis of the global Targeted Protein Degradation Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Protein Degradation Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Protein Degradation Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Protein Degradation Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Protein Degradation Drug.
United States market for Targeted Protein Degradation Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Targeted Protein Degradation Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Targeted Protein Degradation Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Targeted Protein Degradation Drug players cover Arvinas, Kangpu Biopharmaceuticals, Ranok Therapeutics, Accutar Biotechnology and BeiGene Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Protein Degradation Drug market by product type, application, key players and key regions and countries.
Segmentation by type
- PROTAC
- Molecular Glue
- Cancer
- Autoimmune Diseases
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Arvinas
- Kangpu Biopharmaceuticals
- Ranok Therapeutics
- Accutar Biotechnology
- BeiGene Ltd.
- Hinova Pharmaceuticals
- Haisco Pharmaceutical
- Nurix
- Kymera Therapeutics
- C4 Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Protein Degradation Drug Market Size 2019-2030
2.1.2 Targeted Protein Degradation Drug Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Targeted Protein Degradation Drug Segment by Type
2.2.1 PROTAC
2.2.2 Molecular Glue
2.3 Targeted Protein Degradation Drug Market Size by Type
2.3.1 Targeted Protein Degradation Drug Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
2.4 Targeted Protein Degradation Drug Segment by Application
2.4.1 Cancer
2.4.2 Autoimmune Diseases
2.4.3 Other
2.5 Targeted Protein Degradation Drug Market Size by Application
2.5.1 Targeted Protein Degradation Drug Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
3 TARGETED PROTEIN DEGRADATION DRUG MARKET SIZE BY PLAYER
3.1 Targeted Protein Degradation Drug Market Size Market Share by Players
3.1.1 Global Targeted Protein Degradation Drug Revenue by Players (2019-2024)
3.1.2 Global Targeted Protein Degradation Drug Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Protein Degradation Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED PROTEIN DEGRADATION DRUG BY REGIONS
4.1 Targeted Protein Degradation Drug Market Size by Regions (2019-2024)
4.2 Americas Targeted Protein Degradation Drug Market Size Growth (2019-2024)
4.3 APAC Targeted Protein Degradation Drug Market Size Growth (2019-2024)
4.4 Europe Targeted Protein Degradation Drug Market Size Growth (2019-2024)
4.5 Middle East & Africa Targeted Protein Degradation Drug Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Targeted Protein Degradation Drug Market Size by Country (2019-2024)
5.2 Americas Targeted Protein Degradation Drug Market Size by Type (2019-2024)
5.3 Americas Targeted Protein Degradation Drug Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Protein Degradation Drug Market Size by Region (2019-2024)
6.2 APAC Targeted Protein Degradation Drug Market Size by Type (2019-2024)
6.3 APAC Targeted Protein Degradation Drug Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Protein Degradation Drug by Country (2019-2024)
7.2 Europe Targeted Protein Degradation Drug Market Size by Type (2019-2024)
7.3 Europe Targeted Protein Degradation Drug Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Protein Degradation Drug by Region (2019-2024)
8.2 Middle East & Africa Targeted Protein Degradation Drug Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED PROTEIN DEGRADATION DRUG MARKET FORECAST
10.1 Global Targeted Protein Degradation Drug Forecast by Regions (2025-2030)
10.1.1 Global Targeted Protein Degradation Drug Forecast by Regions (2025-2030)
10.1.2 Americas Targeted Protein Degradation Drug Forecast
10.1.3 APAC Targeted Protein Degradation Drug Forecast
10.1.4 Europe Targeted Protein Degradation Drug Forecast
10.1.5 Middle East & Africa Targeted Protein Degradation Drug Forecast
10.2 Americas Targeted Protein Degradation Drug Forecast by Country (2025-2030)
10.2.1 United States Targeted Protein Degradation Drug Market Forecast
10.2.2 Canada Targeted Protein Degradation Drug Market Forecast
10.2.3 Mexico Targeted Protein Degradation Drug Market Forecast
10.2.4 Brazil Targeted Protein Degradation Drug Market Forecast
10.3 APAC Targeted Protein Degradation Drug Forecast by Region (2025-2030)
10.3.1 China Targeted Protein Degradation Drug Market Forecast
10.3.2 Japan Targeted Protein Degradation Drug Market Forecast
10.3.3 Korea Targeted Protein Degradation Drug Market Forecast
10.3.4 Southeast Asia Targeted Protein Degradation Drug Market Forecast
10.3.5 India Targeted Protein Degradation Drug Market Forecast
10.3.6 Australia Targeted Protein Degradation Drug Market Forecast
10.4 Europe Targeted Protein Degradation Drug Forecast by Country (2025-2030)
10.4.1 Germany Targeted Protein Degradation Drug Market Forecast
10.4.2 France Targeted Protein Degradation Drug Market Forecast
10.4.3 UK Targeted Protein Degradation Drug Market Forecast
10.4.4 Italy Targeted Protein Degradation Drug Market Forecast
10.4.5 Russia Targeted Protein Degradation Drug Market Forecast
10.5 Middle East & Africa Targeted Protein Degradation Drug Forecast by Region (2025-2030)
10.5.1 Egypt Targeted Protein Degradation Drug Market Forecast
10.5.2 South Africa Targeted Protein Degradation Drug Market Forecast
10.5.3 Israel Targeted Protein Degradation Drug Market Forecast
10.5.4 Turkey Targeted Protein Degradation Drug Market Forecast
10.5.5 GCC Countries Targeted Protein Degradation Drug Market Forecast
10.6 Global Targeted Protein Degradation Drug Forecast by Type (2025-2030)
10.7 Global Targeted Protein Degradation Drug Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Arvinas
11.1.1 Arvinas Company Information
11.1.2 Arvinas Targeted Protein Degradation Drug Product Offered
11.1.3 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Arvinas Main Business Overview
11.1.5 Arvinas Latest Developments
11.2 Kangpu Biopharmaceuticals
11.2.1 Kangpu Biopharmaceuticals Company Information
11.2.2 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product Offered
11.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Kangpu Biopharmaceuticals Main Business Overview
11.2.5 Kangpu Biopharmaceuticals Latest Developments
11.3 Ranok Therapeutics
11.3.1 Ranok Therapeutics Company Information
11.3.2 Ranok Therapeutics Targeted Protein Degradation Drug Product Offered
11.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ranok Therapeutics Main Business Overview
11.3.5 Ranok Therapeutics Latest Developments
11.4 Accutar Biotechnology
11.4.1 Accutar Biotechnology Company Information
11.4.2 Accutar Biotechnology Targeted Protein Degradation Drug Product Offered
11.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Accutar Biotechnology Main Business Overview
11.4.5 Accutar Biotechnology Latest Developments
11.5 BeiGene Ltd.
11.5.1 BeiGene Ltd. Company Information
11.5.2 BeiGene Ltd. Targeted Protein Degradation Drug Product Offered
11.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BeiGene Ltd. Main Business Overview
11.5.5 BeiGene Ltd. Latest Developments
11.6 Hinova Pharmaceuticals
11.6.1 Hinova Pharmaceuticals Company Information
11.6.2 Hinova Pharmaceuticals Targeted Protein Degradation Drug Product Offered
11.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Hinova Pharmaceuticals Main Business Overview
11.6.5 Hinova Pharmaceuticals Latest Developments
11.7 Haisco Pharmaceutical
11.7.1 Haisco Pharmaceutical Company Information
11.7.2 Haisco Pharmaceutical Targeted Protein Degradation Drug Product Offered
11.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Haisco Pharmaceutical Main Business Overview
11.7.5 Haisco Pharmaceutical Latest Developments
11.8 Nurix
11.8.1 Nurix Company Information
11.8.2 Nurix Targeted Protein Degradation Drug Product Offered
11.8.3 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Nurix Main Business Overview
11.8.5 Nurix Latest Developments
11.9 Kymera Therapeutics
11.9.1 Kymera Therapeutics Company Information
11.9.2 Kymera Therapeutics Targeted Protein Degradation Drug Product Offered
11.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Kymera Therapeutics Main Business Overview
11.9.5 Kymera Therapeutics Latest Developments
11.10 C4 Therapeutics
11.10.1 C4 Therapeutics Company Information
11.10.2 C4 Therapeutics Targeted Protein Degradation Drug Product Offered
11.10.3 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 C4 Therapeutics Main Business Overview
11.10.5 C4 Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Protein Degradation Drug Market Size 2019-2030
2.1.2 Targeted Protein Degradation Drug Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Targeted Protein Degradation Drug Segment by Type
2.2.1 PROTAC
2.2.2 Molecular Glue
2.3 Targeted Protein Degradation Drug Market Size by Type
2.3.1 Targeted Protein Degradation Drug Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
2.4 Targeted Protein Degradation Drug Segment by Application
2.4.1 Cancer
2.4.2 Autoimmune Diseases
2.4.3 Other
2.5 Targeted Protein Degradation Drug Market Size by Application
2.5.1 Targeted Protein Degradation Drug Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
3 TARGETED PROTEIN DEGRADATION DRUG MARKET SIZE BY PLAYER
3.1 Targeted Protein Degradation Drug Market Size Market Share by Players
3.1.1 Global Targeted Protein Degradation Drug Revenue by Players (2019-2024)
3.1.2 Global Targeted Protein Degradation Drug Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Protein Degradation Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED PROTEIN DEGRADATION DRUG BY REGIONS
4.1 Targeted Protein Degradation Drug Market Size by Regions (2019-2024)
4.2 Americas Targeted Protein Degradation Drug Market Size Growth (2019-2024)
4.3 APAC Targeted Protein Degradation Drug Market Size Growth (2019-2024)
4.4 Europe Targeted Protein Degradation Drug Market Size Growth (2019-2024)
4.5 Middle East & Africa Targeted Protein Degradation Drug Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Targeted Protein Degradation Drug Market Size by Country (2019-2024)
5.2 Americas Targeted Protein Degradation Drug Market Size by Type (2019-2024)
5.3 Americas Targeted Protein Degradation Drug Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Protein Degradation Drug Market Size by Region (2019-2024)
6.2 APAC Targeted Protein Degradation Drug Market Size by Type (2019-2024)
6.3 APAC Targeted Protein Degradation Drug Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Protein Degradation Drug by Country (2019-2024)
7.2 Europe Targeted Protein Degradation Drug Market Size by Type (2019-2024)
7.3 Europe Targeted Protein Degradation Drug Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Protein Degradation Drug by Region (2019-2024)
8.2 Middle East & Africa Targeted Protein Degradation Drug Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED PROTEIN DEGRADATION DRUG MARKET FORECAST
10.1 Global Targeted Protein Degradation Drug Forecast by Regions (2025-2030)
10.1.1 Global Targeted Protein Degradation Drug Forecast by Regions (2025-2030)
10.1.2 Americas Targeted Protein Degradation Drug Forecast
10.1.3 APAC Targeted Protein Degradation Drug Forecast
10.1.4 Europe Targeted Protein Degradation Drug Forecast
10.1.5 Middle East & Africa Targeted Protein Degradation Drug Forecast
10.2 Americas Targeted Protein Degradation Drug Forecast by Country (2025-2030)
10.2.1 United States Targeted Protein Degradation Drug Market Forecast
10.2.2 Canada Targeted Protein Degradation Drug Market Forecast
10.2.3 Mexico Targeted Protein Degradation Drug Market Forecast
10.2.4 Brazil Targeted Protein Degradation Drug Market Forecast
10.3 APAC Targeted Protein Degradation Drug Forecast by Region (2025-2030)
10.3.1 China Targeted Protein Degradation Drug Market Forecast
10.3.2 Japan Targeted Protein Degradation Drug Market Forecast
10.3.3 Korea Targeted Protein Degradation Drug Market Forecast
10.3.4 Southeast Asia Targeted Protein Degradation Drug Market Forecast
10.3.5 India Targeted Protein Degradation Drug Market Forecast
10.3.6 Australia Targeted Protein Degradation Drug Market Forecast
10.4 Europe Targeted Protein Degradation Drug Forecast by Country (2025-2030)
10.4.1 Germany Targeted Protein Degradation Drug Market Forecast
10.4.2 France Targeted Protein Degradation Drug Market Forecast
10.4.3 UK Targeted Protein Degradation Drug Market Forecast
10.4.4 Italy Targeted Protein Degradation Drug Market Forecast
10.4.5 Russia Targeted Protein Degradation Drug Market Forecast
10.5 Middle East & Africa Targeted Protein Degradation Drug Forecast by Region (2025-2030)
10.5.1 Egypt Targeted Protein Degradation Drug Market Forecast
10.5.2 South Africa Targeted Protein Degradation Drug Market Forecast
10.5.3 Israel Targeted Protein Degradation Drug Market Forecast
10.5.4 Turkey Targeted Protein Degradation Drug Market Forecast
10.5.5 GCC Countries Targeted Protein Degradation Drug Market Forecast
10.6 Global Targeted Protein Degradation Drug Forecast by Type (2025-2030)
10.7 Global Targeted Protein Degradation Drug Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Arvinas
11.1.1 Arvinas Company Information
11.1.2 Arvinas Targeted Protein Degradation Drug Product Offered
11.1.3 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Arvinas Main Business Overview
11.1.5 Arvinas Latest Developments
11.2 Kangpu Biopharmaceuticals
11.2.1 Kangpu Biopharmaceuticals Company Information
11.2.2 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product Offered
11.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Kangpu Biopharmaceuticals Main Business Overview
11.2.5 Kangpu Biopharmaceuticals Latest Developments
11.3 Ranok Therapeutics
11.3.1 Ranok Therapeutics Company Information
11.3.2 Ranok Therapeutics Targeted Protein Degradation Drug Product Offered
11.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ranok Therapeutics Main Business Overview
11.3.5 Ranok Therapeutics Latest Developments
11.4 Accutar Biotechnology
11.4.1 Accutar Biotechnology Company Information
11.4.2 Accutar Biotechnology Targeted Protein Degradation Drug Product Offered
11.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Accutar Biotechnology Main Business Overview
11.4.5 Accutar Biotechnology Latest Developments
11.5 BeiGene Ltd.
11.5.1 BeiGene Ltd. Company Information
11.5.2 BeiGene Ltd. Targeted Protein Degradation Drug Product Offered
11.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BeiGene Ltd. Main Business Overview
11.5.5 BeiGene Ltd. Latest Developments
11.6 Hinova Pharmaceuticals
11.6.1 Hinova Pharmaceuticals Company Information
11.6.2 Hinova Pharmaceuticals Targeted Protein Degradation Drug Product Offered
11.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Hinova Pharmaceuticals Main Business Overview
11.6.5 Hinova Pharmaceuticals Latest Developments
11.7 Haisco Pharmaceutical
11.7.1 Haisco Pharmaceutical Company Information
11.7.2 Haisco Pharmaceutical Targeted Protein Degradation Drug Product Offered
11.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Haisco Pharmaceutical Main Business Overview
11.7.5 Haisco Pharmaceutical Latest Developments
11.8 Nurix
11.8.1 Nurix Company Information
11.8.2 Nurix Targeted Protein Degradation Drug Product Offered
11.8.3 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Nurix Main Business Overview
11.8.5 Nurix Latest Developments
11.9 Kymera Therapeutics
11.9.1 Kymera Therapeutics Company Information
11.9.2 Kymera Therapeutics Targeted Protein Degradation Drug Product Offered
11.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Kymera Therapeutics Main Business Overview
11.9.5 Kymera Therapeutics Latest Developments
11.10 C4 Therapeutics
11.10.1 C4 Therapeutics Company Information
11.10.2 C4 Therapeutics Targeted Protein Degradation Drug Product Offered
11.10.3 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 C4 Therapeutics Main Business Overview
11.10.5 C4 Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Protein Degradation Drug Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of PROTAC
Table 3. Major Players of Molecular Glue
Table 4. Targeted Protein Degradation Drug Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Targeted Protein Degradation Drug Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Table 7. Targeted Protein Degradation Drug Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Targeted Protein Degradation Drug Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Table 10. Global Targeted Protein Degradation Drug Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Targeted Protein Degradation Drug Revenue Market Share by Player (2019-2024)
Table 12. Targeted Protein Degradation Drug Key Players Head office and Products Offered
Table 13. Targeted Protein Degradation Drug Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Targeted Protein Degradation Drug Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Targeted Protein Degradation Drug Market Size Market Share by Regions (2019-2024)
Table 18. Global Targeted Protein Degradation Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Targeted Protein Degradation Drug Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Targeted Protein Degradation Drug Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Targeted Protein Degradation Drug Market Size Market Share by Country (2019-2024)
Table 22. Americas Targeted Protein Degradation Drug Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Table 24. Americas Targeted Protein Degradation Drug Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Table 26. APAC Targeted Protein Degradation Drug Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Targeted Protein Degradation Drug Market Size Market Share by Region (2019-2024)
Table 28. APAC Targeted Protein Degradation Drug Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Table 30. APAC Targeted Protein Degradation Drug Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Table 32. Europe Targeted Protein Degradation Drug Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Targeted Protein Degradation Drug Market Size Market Share by Country (2019-2024)
Table 34. Europe Targeted Protein Degradation Drug Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Table 36. Europe Targeted Protein Degradation Drug Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Targeted Protein Degradation Drug Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Targeted Protein Degradation Drug Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Targeted Protein Degradation Drug Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Targeted Protein Degradation Drug
Table 45. Key Market Challenges & Risks of Targeted Protein Degradation Drug
Table 46. Key Industry Trends of Targeted Protein Degradation Drug
Table 47. Global Targeted Protein Degradation Drug Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Targeted Protein Degradation Drug Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Targeted Protein Degradation Drug Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Arvinas Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 52. Arvinas Targeted Protein Degradation Drug Product Offered
Table 53. Arvinas Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Arvinas Main Business
Table 55. Arvinas Latest Developments
Table 56. Kangpu Biopharmaceuticals Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 57. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product Offered
Table 58. Kangpu Biopharmaceuticals Main Business
Table 59. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Kangpu Biopharmaceuticals Latest Developments
Table 61. Ranok Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 62. Ranok Therapeutics Targeted Protein Degradation Drug Product Offered
Table 63. Ranok Therapeutics Main Business
Table 64. Ranok Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Ranok Therapeutics Latest Developments
Table 66. Accutar Biotechnology Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 67. Accutar Biotechnology Targeted Protein Degradation Drug Product Offered
Table 68. Accutar Biotechnology Main Business
Table 69. Accutar Biotechnology Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Accutar Biotechnology Latest Developments
Table 71. BeiGene Ltd. Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 72. BeiGene Ltd. Targeted Protein Degradation Drug Product Offered
Table 73. BeiGene Ltd. Main Business
Table 74. BeiGene Ltd. Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. BeiGene Ltd. Latest Developments
Table 76. Hinova Pharmaceuticals Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 77. Hinova Pharmaceuticals Targeted Protein Degradation Drug Product Offered
Table 78. Hinova Pharmaceuticals Main Business
Table 79. Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Hinova Pharmaceuticals Latest Developments
Table 81. Haisco Pharmaceutical Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 82. Haisco Pharmaceutical Targeted Protein Degradation Drug Product Offered
Table 83. Haisco Pharmaceutical Main Business
Table 84. Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Haisco Pharmaceutical Latest Developments
Table 86. Nurix Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 87. Nurix Targeted Protein Degradation Drug Product Offered
Table 88. Nurix Main Business
Table 89. Nurix Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Nurix Latest Developments
Table 91. Kymera Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 92. Kymera Therapeutics Targeted Protein Degradation Drug Product Offered
Table 93. Kymera Therapeutics Main Business
Table 94. Kymera Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Kymera Therapeutics Latest Developments
Table 96. C4 Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 97. C4 Therapeutics Targeted Protein Degradation Drug Product Offered
Table 98. C4 Therapeutics Main Business
Table 99. C4 Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. C4 Therapeutics Latest Developments
Table 1. Targeted Protein Degradation Drug Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of PROTAC
Table 3. Major Players of Molecular Glue
Table 4. Targeted Protein Degradation Drug Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Targeted Protein Degradation Drug Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Table 7. Targeted Protein Degradation Drug Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Targeted Protein Degradation Drug Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Table 10. Global Targeted Protein Degradation Drug Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Targeted Protein Degradation Drug Revenue Market Share by Player (2019-2024)
Table 12. Targeted Protein Degradation Drug Key Players Head office and Products Offered
Table 13. Targeted Protein Degradation Drug Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Targeted Protein Degradation Drug Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Targeted Protein Degradation Drug Market Size Market Share by Regions (2019-2024)
Table 18. Global Targeted Protein Degradation Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Targeted Protein Degradation Drug Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Targeted Protein Degradation Drug Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Targeted Protein Degradation Drug Market Size Market Share by Country (2019-2024)
Table 22. Americas Targeted Protein Degradation Drug Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Table 24. Americas Targeted Protein Degradation Drug Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Table 26. APAC Targeted Protein Degradation Drug Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Targeted Protein Degradation Drug Market Size Market Share by Region (2019-2024)
Table 28. APAC Targeted Protein Degradation Drug Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Table 30. APAC Targeted Protein Degradation Drug Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Table 32. Europe Targeted Protein Degradation Drug Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Targeted Protein Degradation Drug Market Size Market Share by Country (2019-2024)
Table 34. Europe Targeted Protein Degradation Drug Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Table 36. Europe Targeted Protein Degradation Drug Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Targeted Protein Degradation Drug Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Targeted Protein Degradation Drug Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Targeted Protein Degradation Drug Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Targeted Protein Degradation Drug
Table 45. Key Market Challenges & Risks of Targeted Protein Degradation Drug
Table 46. Key Industry Trends of Targeted Protein Degradation Drug
Table 47. Global Targeted Protein Degradation Drug Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Targeted Protein Degradation Drug Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Targeted Protein Degradation Drug Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Arvinas Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 52. Arvinas Targeted Protein Degradation Drug Product Offered
Table 53. Arvinas Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Arvinas Main Business
Table 55. Arvinas Latest Developments
Table 56. Kangpu Biopharmaceuticals Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 57. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product Offered
Table 58. Kangpu Biopharmaceuticals Main Business
Table 59. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Kangpu Biopharmaceuticals Latest Developments
Table 61. Ranok Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 62. Ranok Therapeutics Targeted Protein Degradation Drug Product Offered
Table 63. Ranok Therapeutics Main Business
Table 64. Ranok Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Ranok Therapeutics Latest Developments
Table 66. Accutar Biotechnology Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 67. Accutar Biotechnology Targeted Protein Degradation Drug Product Offered
Table 68. Accutar Biotechnology Main Business
Table 69. Accutar Biotechnology Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Accutar Biotechnology Latest Developments
Table 71. BeiGene Ltd. Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 72. BeiGene Ltd. Targeted Protein Degradation Drug Product Offered
Table 73. BeiGene Ltd. Main Business
Table 74. BeiGene Ltd. Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. BeiGene Ltd. Latest Developments
Table 76. Hinova Pharmaceuticals Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 77. Hinova Pharmaceuticals Targeted Protein Degradation Drug Product Offered
Table 78. Hinova Pharmaceuticals Main Business
Table 79. Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Hinova Pharmaceuticals Latest Developments
Table 81. Haisco Pharmaceutical Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 82. Haisco Pharmaceutical Targeted Protein Degradation Drug Product Offered
Table 83. Haisco Pharmaceutical Main Business
Table 84. Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Haisco Pharmaceutical Latest Developments
Table 86. Nurix Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 87. Nurix Targeted Protein Degradation Drug Product Offered
Table 88. Nurix Main Business
Table 89. Nurix Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Nurix Latest Developments
Table 91. Kymera Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 92. Kymera Therapeutics Targeted Protein Degradation Drug Product Offered
Table 93. Kymera Therapeutics Main Business
Table 94. Kymera Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Kymera Therapeutics Latest Developments
Table 96. C4 Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 97. C4 Therapeutics Targeted Protein Degradation Drug Product Offered
Table 98. C4 Therapeutics Main Business
Table 99. C4 Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. C4 Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Targeted Protein Degradation Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Protein Degradation Drug Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Targeted Protein Degradation Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Targeted Protein Degradation Drug Sales Market Share by Country/Region (2023)
Figure 8. Targeted Protein Degradation Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Targeted Protein Degradation Drug Market Size Market Share by Type in 2023
Figure 10. Targeted Protein Degradation Drug in Cancer
Figure 11. Global Targeted Protein Degradation Drug Market: Cancer (2019-2024) & ($ Millions)
Figure 12. Targeted Protein Degradation Drug in Autoimmune Diseases
Figure 13. Global Targeted Protein Degradation Drug Market: Autoimmune Diseases (2019-2024) & ($ Millions)
Figure 14. Targeted Protein Degradation Drug in Other
Figure 15. Global Targeted Protein Degradation Drug Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Targeted Protein Degradation Drug Market Size Market Share by Application in 2023
Figure 17. Global Targeted Protein Degradation Drug Revenue Market Share by Player in 2023
Figure 18. Global Targeted Protein Degradation Drug Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Targeted Protein Degradation Drug Market Size 2019-2024 ($ Millions)
Figure 20. APAC Targeted Protein Degradation Drug Market Size 2019-2024 ($ Millions)
Figure 21. Europe Targeted Protein Degradation Drug Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Targeted Protein Degradation Drug Market Size 2019-2024 ($ Millions)
Figure 23. Americas Targeted Protein Degradation Drug Value Market Share by Country in 2023
Figure 24. United States Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Targeted Protein Degradation Drug Market Size Market Share by Region in 2023
Figure 29. APAC Targeted Protein Degradation Drug Market Size Market Share by Type in 2023
Figure 30. APAC Targeted Protein Degradation Drug Market Size Market Share by Application in 2023
Figure 31. China Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Targeted Protein Degradation Drug Market Size Market Share by Country in 2023
Figure 38. Europe Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Figure 39. Europe Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Figure 40. Germany Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 54. APAC Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 55. Europe Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 57. United States Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 58. Canada Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 61. China Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 62. Japan Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 63. Korea Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 65. India Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 66. Australia Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 67. Germany Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 68. France Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 69. UK Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 70. Italy Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 71. Russia Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 72. Spain Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 75. Israel Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 78. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Targeted Protein Degradation Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Protein Degradation Drug Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Targeted Protein Degradation Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Targeted Protein Degradation Drug Sales Market Share by Country/Region (2023)
Figure 8. Targeted Protein Degradation Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Targeted Protein Degradation Drug Market Size Market Share by Type in 2023
Figure 10. Targeted Protein Degradation Drug in Cancer
Figure 11. Global Targeted Protein Degradation Drug Market: Cancer (2019-2024) & ($ Millions)
Figure 12. Targeted Protein Degradation Drug in Autoimmune Diseases
Figure 13. Global Targeted Protein Degradation Drug Market: Autoimmune Diseases (2019-2024) & ($ Millions)
Figure 14. Targeted Protein Degradation Drug in Other
Figure 15. Global Targeted Protein Degradation Drug Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Targeted Protein Degradation Drug Market Size Market Share by Application in 2023
Figure 17. Global Targeted Protein Degradation Drug Revenue Market Share by Player in 2023
Figure 18. Global Targeted Protein Degradation Drug Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Targeted Protein Degradation Drug Market Size 2019-2024 ($ Millions)
Figure 20. APAC Targeted Protein Degradation Drug Market Size 2019-2024 ($ Millions)
Figure 21. Europe Targeted Protein Degradation Drug Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Targeted Protein Degradation Drug Market Size 2019-2024 ($ Millions)
Figure 23. Americas Targeted Protein Degradation Drug Value Market Share by Country in 2023
Figure 24. United States Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Targeted Protein Degradation Drug Market Size Market Share by Region in 2023
Figure 29. APAC Targeted Protein Degradation Drug Market Size Market Share by Type in 2023
Figure 30. APAC Targeted Protein Degradation Drug Market Size Market Share by Application in 2023
Figure 31. China Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Targeted Protein Degradation Drug Market Size Market Share by Country in 2023
Figure 38. Europe Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Figure 39. Europe Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Figure 40. Germany Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Targeted Protein Degradation Drug Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 54. APAC Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 55. Europe Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 57. United States Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 58. Canada Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 61. China Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 62. Japan Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 63. Korea Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 65. India Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 66. Australia Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 67. Germany Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 68. France Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 69. UK Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 70. Italy Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 71. Russia Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 72. Spain Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 75. Israel Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Targeted Protein Degradation Drug Market Size 2025-2030 ($ Millions)
Figure 78. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Application (2025-2030)
